Search Results 61-70 of 13082 for Alcoholics

  1. Liver problems - Symptoms and causes - Mayo Clinic

    Fatty liver disease — alcoholic and nonalcoholic: Similar but different. International Journal of Molecular Sciences. 2022; doi:10.3390/ijms232416226 ...

  2. Terry D. Schneekloth, M.D. - Mayo Clinic Faculty Profiles

    Focus areas. Outcomes of addiction treatment and Alcoholics Anonymous attendance before and after a transplant. Dr. Schneekloth has previously published on the ...

  3. A Study of the Use of a New Drug in People with Non-Alcoholic Steatohepatitis (NASH) or Non-Alcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

    The purpose of this study is to assess a new drug to decrease liver fat in subjects with Non-Alcoholic Steatohepatitis or Non-Alcoholic Fatty Liver Disease.

  4. Liver function tests - Mayo Clinic

    Monitor a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working. Look for signs of serious disease, particularly ...

  5. Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) - Mayo Clinic

    Clinical Trials · Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) · More about research at Mayo Clinic · Mayo ...

  6. Fetal alcohol syndrome - Diagnosis and treatment - Mayo Clinic

    Joining a support group or 12-step program such as Alcoholics Anonymous also may help. Request an appointment. Coping and support. The challenges that occur ...

  7. Alcohol poisoning - Diagnosis and treatment - Mayo Clinic

    Monitoring to prevent breathing or choking problems. Oxygen therapy. Fluids given through a vein to prevent dehydration. Use of vitamins and glucose to help ...

  8. Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

    Clinical Trials · Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis · More about research at Mayo ...

  9. Housecall: Alcohol - risks, benefits and why moderation is key - Mayo Clinic News Network

    Share this: Share to facebook · Share to twitter · Share to linkedin · Share to email Print. different kinds of alcoholic drinks in various glasses with a white ...

  10. Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension - Mayo Clinic

    Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension · More about research at ...